Akkermansia muciniphila – a promising candidate for a next generation probiotic

[1]Cani P.D.: Human gut microbiome: Hopes, threats and promises. Gut, 2018; 67: 1716-1725 Cani P.D. Human gut microbiome: Hopes, threats and promises Gut 2018 67 1716 172510.1136/gutjnl-2018-316723610927529934437Search in Google Scholar

[2]Berg G., Rybakova D., Fischer D., Cernava T., Vergès M.C., Charles T., Chen X., Cocolin L., Eversole K., Corral G.H. i wsp.: Microbiome definition re-visited: Old concepts and new challenges. Microbiome, 2020; 8: 103 Berg G. Rybakova D. Fischer D. Cernava T. Vergès M.C. Charles T. Chen X. Cocolin L. Eversole K. Corral G.H. i wsp. Microbiome definition re-visited: Old concepts and new challenges Microbiome 2020 8 10310.1186/s40168-020-00875-0732952332605663Search in Google Scholar

[3]Sender R., Fuchs S., Milo R.: Revised estimates for the number of human and bacteria cells in the body. PLoS Biol, 2016; 14: e1002533 Sender R. Fuchs S. Milo R. Revised estimates for the number of human and bacteria cells in the body PLoS Biol 2016 14 e100253310.1371/journal.pbio.1002533499189927541692Search in Google Scholar

[4]Dominguez-Bello M.G., Godoy-Vitorino F., Knight R., Blaser M.J.: Role of the microbiome in human development. Gut, 2019; 68: 1108-1114 Dominguez-Bello M.G. Godoy-Vitorino F. Knight R. Blaser M.J. Role of the microbiome in human development Gut 2019 68 1108 111410.1136/gutjnl-2018-317503658075530670574Search in Google Scholar

[5]Gomez de Agüero M., Ganal-Vonarburg S.C., Fuhrer T., Rupp S., Uchimura Y., Li H., Steinert A., Heikenwalder M., Hapfelmeier S., Sauer U. i wsp.: The maternal microbiota drives early postnatal innate immune development. Science, 2016; 351: 1296-1302 Gomez de Agüero M. Ganal-Vonarburg S.C. Fuhrer T. Rupp S. Uchimura Y. Li H. Steinert A. Heikenwalder M. Hapfelmeier S. Sauer U. i wsp. The maternal microbiota drives early postnatal innate immune development Science 2016 351 1296 130210.1126/science.aad257126989247Search in Google Scholar

[6]Koren O., Goodrich J.K., Cullender T.C., Spor A, Laitinen K., Bäckhed H.K., Gonzalez A., Werner J.J., Angenent L.T., Knight R. i wsp.: Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell, 2012; 150: 470-480 Koren O. Goodrich J.K. Cullender T.C. Spor A Laitinen K. Bäckhed H.K. Gonzalez A. Werner J.J. Angenent L.T. Knight R. i wsp. Host remodeling of the gut microbiome and metabolic changes during pregnancy Cell 2012 150 470 48010.1016/j.cell.2012.07.008350585722863002Search in Google Scholar

[7]Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y.: Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 2013; 504: 451-455 Arpaia N. Campbell C. Fan X. Dikiy S. van der Veeken J. deRoos P. Liu H. Cross J.R. Pfeffer K. Coffer P.J. Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation Nature 2013 504 451 45510.1038/nature12726386988424226773Search in Google Scholar

[8]David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A. i wsp.: Diet rapidly and reproducibly alters the human gut microbiome. Nature, 2014; 505: 559-563 David L.A. Maurice C.F. Carmody R.N. Gootenberg D.B. Button J.E. Wolfe B.E. Ling A.V. Devlin A.S. Varma Y. Fischbach M.A. i wsp. Diet rapidly and reproducibly alters the human gut microbiome Nature 2014 505 559 56310.1038/nature12820395742824336217Search in Google Scholar

[9]Chang C.J., Lin T.L., Tsai Y.L., Wu T.R., Lai W.F., Lu C.C., Lai H.C.: Next generation probiotics in disease amelioration. J. Food Drug Anal., 2019; 27: 615-622 Chang C.J. Lin T.L. Tsai Y.L. Wu T.R. Lai W.F. Lu C.C. Lai H.C. Next generation probiotics in disease amelioration J. Food Drug Anal 2019 27 615 62210.1016/j.jfda.2018.12.01131324278Search in Google Scholar

[10]Martín R., Langella P.: Emerging health concepts in the probiotics field: Streamlining the definitions. Front. Microbiol., 2019; 10: 1047 Martín R. Langella P. Emerging health concepts in the probiotics field: Streamlining the definitions Front. Microbiol 2019 10 104710.3389/fmicb.2019.01047653665631164874Search in Google Scholar

[11]Naito Y., Uchiyama K., Takagi T.: A next-generation beneficial microbe: Akkermansia muciniphila. J. Clin. Biochem. Nutr., 2018; 63: 33-35 Naito Y. Uchiyama K. Takagi T. A next-generation beneficial microbe: Akkermansia muciniphila J. Clin. Biochem. Nutr 2018 63 33 3510.3164/jcbn.18-57606480830087541Search in Google Scholar

[12]Zhang T., Li Q., Cheng L., Buch H., Zhang F.: Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol., 2019; 12:1109-1125 Zhang T. Li Q. Cheng L. Buch H. Zhang F. Akkermansia muciniphila is a promising probiotic Microb. Biotechnol 2019 121109 112510.1111/1751-7915.13410680113631006995Search in Google Scholar

[13]Gupta R.S., Bhandari V., Naushad H.S.: Molecular signatures for the PVC clade (Planctomycetes, Verrucomicrobia, Chlamydiae, and Lentisphaerae) of bacteria provide insights into their evolutionary relationships. Front. Microbiol., 2012; 3: 327 Gupta R.S. Bhandari V. Naushad H.S. Molecular signatures for the PVC clade (Planctomycetes, Verrucomicrobia, Chlamydiae, and Lentisphaerae) of bacteria provide insights into their evolutionary relationships Front. Microbiol 2012 3 32710.3389/fmicb.2012.00327344413823060863Search in Google Scholar

[14]Derrien M., van Passel M.W., van de Bovenkamp J.H., Schipper R.G., de Vos W.M., Dekker J.: Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes, 2010; 1: 254-268 Derrien M. van Passel M.W. van de Bovenkamp J.H. Schipper R.G. de Vos W.M. Dekker J. Mucin-bacterial interactions in the human oral cavity and digestive tract Gut Microbes 2010 1 254 26810.4161/gmic.1.4.12778302360721327032Search in Google Scholar

[15]Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M.: Akker-mansia muciniphila gen. nov., sp. nov., a human intestinal mucindegrading bacterium. Int. J. Syst. Evol. Microbiol., 2004; 54: 1469-1476 Derrien M. Vaughan E.E. Plugge C.M. de Vos W.M. Akker-mansia muciniphila gen nov., sp. nov., a human intestinal mucindegrading bacterium. Int. J. Syst. Evol. Microbiol 2004 54 1469 147610.1099/ijs.0.02873-015388697Search in Google Scholar

[16]NCBI Taxonomy Browser. https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&id=74201&lvl=6&lin=f&-keep=1&srchmode=1&unlock (25.11.19) NCBI Taxonomy Browser https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&id=74201&lvl=6&lin=f&-keep=1&srchmode=1&unlock (25.11.19)Search in Google Scholar

[17]Geerlings S.Y., Kostopoulos I., de Vos W.M., Belzer C.: Akker-mansia muciniphila in the human gastrointestinal tract: When, where, and how? Microorganisms, 2018; 6: 75 Geerlings S.Y. Kostopoulos I. de Vos W.M. Belzer C. Akker-mansia muciniphila in the human gastrointestinal tract: When, where, and how? Microorganisms 2018 6 7510.3390/microorganisms6030075616324330041463Search in Google Scholar

[18]Ottman N., Geerlings S.Y., Aalvink S., de Vos W.M., Belzer C.: Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract. Res. Clin. Gastroenterol., 2017; 31: 637-642 Ottman N. Geerlings S.Y. Aalvink S. de Vos W.M. Belzer C. Action and function of Akkermansia muciniphila in microbiome ecology, health and disease Best Pract. Res. Clin. Gastroenterol 2017 31 637 64210.1016/j.bpg.2017.10.00129566906Search in Google Scholar

[19]Ottman N., Davids M., Suarez-Diez M., Boeren S., Schaap P.J., Martins Dos Santos V.A., Smidt H., Belzer C., de Vos W.M.: Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol., 2017; 83: e01014-17 Ottman N. Davids M. Suarez-Diez M. Boeren S. Schaap P.J. Martins Dos Santos V.A. Smidt H. Belzer C. de Vos W.M. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle Appl. Environ. Microbiol 2017 83 e01014 1710.1128/AEM.01014-17558348328687644Search in Google Scholar

[20]Collado M.C., Derrien M., Isolauri E., de Vos W.M., Salminen S.: Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol., 2007; 73: 7767-7770 Collado M.C. Derrien M. Isolauri E. de Vos W.M. Salminen S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly Appl. Environ. Microbiol 2007 73 7767 777010.1128/AEM.01477-07216804117933936Search in Google Scholar

[21]Cozzolino A., Vergalito F., Tremonte P., Iorizzo M., Lombardi S. J., Sorrentino E., Luongo D., Coppola R., Di Marco R., Succi M.: Preliminary evaluation of the safety and probiotic potential of Ak-kermansia muciniphila DSM 22959 in comparison with Lactobacil-lus rhamnosus GG. Microorganisms, 2020; 8: 189 Cozzolino A. Vergalito F. Tremonte P. Iorizzo M. Lombardi S. J. Sorrentino E. Luongo D. Coppola R. Di Marco R. Succi M. Preliminary evaluation of the safety and probiotic potential of Ak-kermansia muciniphila DSM 22959 in comparison with Lactobacil-lus rhamnosus GG Microorganisms 2020 8 18910.3390/microorganisms8020189707480532019075Search in Google Scholar

[22]Depommier C., Everard A., Druart C., Plovier H., Van Hul M., Vieira-Silva S., Falony G., Raes J., Maiter D., Delzenne N.M. i wsp.: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat. Med., 2019; 25: 1096-1103 Depommier C. Everard A. Druart C. Plovier H. Van Hul M. Vieira-Silva S. Falony G. Raes J. Maiter D. Delzenne N.M. i wsp. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study Nat. Med 2019 25 1096 110310.1038/s41591-019-0495-2669999031263284Search in Google Scholar

[23]Johansson M.E., Larsson J.M., Hansson G.C.: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA, 2011; 108: 4659-4665 Johansson M.E. Larsson J.M. Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions Proc. Natl. Acad. Sci. USA 2011 108 4659 466510.1073/pnas.1006451107306360020615996Search in Google Scholar

[24]Lopez-Siles M., Enrich-Capó N., Aldeguer X., Sabat-Mir M., Duncan S.H., Garcia-Gil L.J., Martinez-Medina M.: Alterations in the abundance and co-occurrence of Akkermansia muciniph-ila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front. Cell. Infect. Microbiol., 2018; 8: 281 Lopez-Siles M. Enrich-Capó N. Aldeguer X. Sabat-Mir M. Duncan S.H. Garcia-Gil L.J. Martinez-Medina M. Alterations in the abundance and co-occurrence of Akkermansia muciniph-ila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects Front. Cell. Infect. Microbiol 2018 8 28110.3389/fcimb.2018.00281613795930245977Search in Google Scholar

[25]Zhang T., Li P. Wu X., Lu G., Marcella C., Ji X., Ji G., Zhang F.: Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation. Appl. Microbiol. Biotechnol., 2020; 104: 10203-10215 Zhang T. Li P. Wu X. Lu G. Marcella C. Ji X. Ji G. Zhang F. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation Appl. Microbiol. Biotechnol 2020 104 10203 1021510.1007/s00253-020-10948-733064186Search in Google Scholar

[26]Nava G.M., Carbonero F., Croix J.A., Greenberg E., Gaskins H.R.: Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J., 2012; 6: 57-70 Nava G.M. Carbonero F. Croix J.A. Greenberg E. Gaskins H.R. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon ISME J 2012 6 57 7010.1038/ismej.2011.90324624621753800Search in Google Scholar

[27]Grander C., Adolph T.E., Wieser V., Low, P., Wrzosek L., Gyongyosi B., Ward D.V., Grabherr F., Gerner R.R., Pfister A. i wsp.: Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut, 2018; 67: 891-901 Grander C. Adolph T.E. Wieser V. Low P. Wrzosek L. Gyongyosi B. Ward D.V. Grabherr F. Gerner R.R. Pfister A. i wsp. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease Gut 2018 67 891 90110.1136/gutjnl-2016-31343228550049Search in Google Scholar

[28]Hänninen A., Toivonen R., Pöysti S., Belzer C., Plovier H., Ouwerkerk J.P., Emani R., Cani P.D., De Vos W.M.: Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut, 2018; 67: 1445-1453 Hänninen A. Toivonen R. Pöysti S. Belzer C. Plovier H. Ouwerkerk J.P. Emani R. Cani P.D. De Vos W.M. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice Gut 2018 67 1445 145310.1136/gutjnl-2017-31450829269438Search in Google Scholar

[29]Viggiano D., Ianiro G., Vanella G., Bibbò S., Bruno G., Simeone G., Mele G.: Gut barrier in health and disease: Focus on childhood. Eur. Rev. Med. Pharmacol. Sci., 2015; 19: 1077-1085 Viggiano D. Ianiro G. Vanella G. Bibbò S. Bruno G. Simeone G. Mele G. Gut barrier in health and disease: Focus on childhood Eur. Rev. Med. Pharmacol. Sci 2015 19 1077 1085Search in Google Scholar

[30]Hamada H., Hiroi T., Nishiyama Y., Takahashi H., Masunaga Y., Hachimura S., Kaminogawa S., Takahashi-Iwanaga H., Iwanaga T., Kiyono H. i wsp.: Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol., 2002; 168: 57-64 Hamada H. Hiroi T. Nishiyama Y. Takahashi H. Masunaga Y. Hachimura S. Kaminogawa S. Takahashi-Iwanaga H. Iwanaga T. Kiyono H. i wsp. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine J. Immunol 2002 168 57 6410.4049/jimmunol.168.1.5711751946Search in Google Scholar

[31]Jung C., Hugot J.P., Barreau F.: Peyer’s patches: The immune sensors of the intestine. Int. J. Inflam., 2010; 2010: 823710 Jung C. Hugot J.P. Barreau F. Peyer’s patches: The immune sensors of the intestine Int. J. Inflam 2010 2010 82371010.4061/2010/823710300400021188221Search in Google Scholar

[32]Gomes A.C., Hoffmann C., Mota J.F.: The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes, 2018; 9: 308-325 Gomes A.C. Hoffmann C. Mota J.F. The human gut microbiota: Metabolism and perspective in obesity Gut Microbes 2018 9 308 32510.1080/19490976.2018.1465157621965129667480Search in Google Scholar

[33]UniProtKB - P51684 (CCR6_HUMAN). https://www.uniprot.org/uniprot/P51684 (19.03.2020) UniProtKB - P51684 (CCR6_HUMAN) https://www.uniprot.org/uniprot/P51684 (19.03.2020)Search in Google Scholar

[34]Lin Y.L., Ip P.P., Liao F.: CCR6 deficiency impairs IgA production and dysregulates antimicrobial peptide production, altering the intestinal flora. Front. Immunol., 2017; 8: 805 Lin Y.L. Ip P.P. Liao F. CCR6 deficiency impairs IgA production and dysregulates antimicrobial peptide production, altering the intestinal flora Front. Immunol 2017 8 80510.3389/fimmu.2017.00805550418828744287Search in Google Scholar

[35]Mazzurana L., Rao A., Van Acker A., Mjösberg J.: The roles for innate lymphoid cells in the human immune system. Semin. Immunopathol., 2018; 40: 407-419 Mazzurana L. Rao A. Van Acker A. Mjösberg J. The roles for innate lymphoid cells in the human immune system Semin. Immunopathol 2018 40 407 41910.1007/s00281-018-0688-7606084929948108Search in Google Scholar

[36]UniProtKB - Q6UW15 (REG3G_HUMAN). https://www.uniprot.org/uniprot/Q6UW15 (19.03.2020) UniProtKB - Q6UW15 (REG3G_HUMAN) https://www.uniprot.org/uniprot/Q6UW15 (19.03.2020)Search in Google Scholar

[37]Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M. i wsp.: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA, 2013; 110: 9066-9071 Everard A. Belzer C. Geurts L. Ouwerkerk J.P. Druart C. Bindels L.B. Guiot Y. Derrien M. Muccioli G.G. Delzenne N.M. i wsp. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc. Natl. Acad. Sci. USA 2013 110 9066 907110.1073/pnas.1219451110367039823671105Search in Google Scholar

[38]Pourahmad J., Salimi A.: Isolated human peripheral blood mononuclear cell (PBMC), a cost effective tool for predicting immunosuppressive effects of drugs and xenobiotics. Iran. J. Pharm. Res., 2015; 14: 979 Pourahmad J. Salimi A. Isolated human peripheral blood mononuclear cell (PBMC), a cost effective tool for predicting immunosuppressive effects of drugs and xenobiotics Iran. J. Pharm. Res 2015 14 979Search in Google Scholar

[39]Ottman N., Reunanen J., Meijerink M., Pietilä T.E., Kainulainen V., Klievink J., Huuskonen L., Aalvink S., Skurnik M., Boeren S. i wsp.: Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One, 2017; 12: e0173004 Ottman N. Reunanen J. Meijerink M. Pietilä T.E. Kainulainen V. Klievink J. Huuskonen L. Aalvink S. Skurnik M. Boeren S. i wsp. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function PLoS One 2017 12 e017300410.1371/journal.pone.0173004533211228249045Search in Google Scholar

[40]Hiippala K., Jouhten H., Ronkainen A., Hartikainen A., Kainulainen V., Jalanka J., Satokari R.: The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients, 2018; 10: 988 Hiippala K. Jouhten H. Ronkainen A. Hartikainen A. Kainulainen V. Jalanka J. Satokari R. The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation Nutrients 2018 10 98810.3390/nu10080988611613830060606Search in Google Scholar

[41]Reunanen J., Kainulainen V., Huuskonen L., Ottman N., Belzer C., Huhtinen H., de Vos W.M., Satokari R.: Akkermansia mucin-iphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microbiol., 2015; 81: 36553662 Reunanen J. Kainulainen V. Huuskonen L. Ottman N. Belzer C. Huhtinen H. de Vos W.M. Satokari R. Akkermansia mucin-iphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer Appl. Environ. Microbiol 2015 81 3655366210.1128/AEM.04050-14Search in Google Scholar

[42]Delgado S., Sánchez B., Margolles A., Ruas-Madiedo P., Ruiz L.: Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity. Nutrients, 2020; 12: 391 Delgado S. Sánchez B. Margolles A. Ruas-Madiedo P. Ruiz L. Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity Nutrients 2020 12 39110.3390/nu12020391707122132024101Search in Google Scholar

[43]Hills R.D.Jr., Pontefract B.A., Mishcon H.R., Black C.A., Sutton S.C., Theberge C.R.: Gut microbiome: Profound implications for diet and disease. Nutrients, 2019; 11: 1613 Hills R.D.Jr. Pontefract B.A. Mishcon H.R. Black C.A. Sutton S.C. Theberge C.R. Gut microbiome: Profound implications for diet and disease Nutrients 2019 11 161310.3390/nu11071613668290431315227Search in Google Scholar

[44]Kimura I., Inoue D., Hirano K., Tsujimoto G.: The SCFA receptor GPR43 and energy metabolism. Front. Endocrinol., 2014; 5: 85 Kimura I. Inoue D. Hirano K. Tsujimoto G. The SCFA receptor GPR43 and energy metabolism Front. Endocrinol 2014 5 8510.3389/fendo.2014.00085404648724926285Search in Google Scholar

[45]Andersen A., Lund A., Knop F.K., Vilsbøll T.: Glucagon-like peptide 1 in health and disease. Nat. Rev. Endocrinol., 2018; 14: 390-403 Andersen A. Lund A. Knop F.K. Vilsbøll T. Glucagon-like peptide 1 in health and disease Nat. Rev. Endocrinol 2018 14 390 40310.1038/s41574-018-0016-229728598Search in Google Scholar

[46]Vásquez-Garibay E., Larrosa-Haro A., Guzmán-Mercado E., Muñoz-Esparza N., García-Arellano S., Muñoz-Valle F., Romero-Velarde E.: Appetite-regulating hormones and anthropometric indicators of infants according to the type of feeding. Food Sci. Nutr., 2020; 8: 993-1000 Vásquez-Garibay E. Larrosa-Haro A. Guzmán-Mercado E. Muñoz-Esparza N. García-Arellano S. Muñoz-Valle F. Romero-Velarde E. Appetite-regulating hormones and anthropometric indicators of infants according to the type of feeding Food Sci. Nutr 2020 8 993 100010.1002/fsn3.1381702026532148807Search in Google Scholar

[47]Chang P.V., Hao L., Offermanns S., Medzhitov R.: The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA, 2014; 111: 2247-2252 Chang P.V. Hao L. Offermanns S. Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition Proc. Natl. Acad. Sci. USA 2014 111 2247 225210.1073/pnas.1322269111392602324390544Search in Google Scholar

[48]Liu H., Wang J., He T., Becker S., Zhang G., Li D., Ma X.: Butyrate: A double-edged sword for health? Adv. Nutr., 2018; 9: 21-29 Liu H. Wang J. He T. Becker S. Zhang G. Li D. Ma X. Butyrate: A double-edged sword for health? Adv Nutr 2018 9 21 2910.1093/advances/nmx009633393429438462Search in Google Scholar

[49]Eckschlager T., Plch J., Stiborova M., Hrabeta J.: Histone deacetylase inhibitors as anticancer drugs. Int. J. Mol. Sci., 2017; 18: 1414 Eckschlager T. Plch J. Stiborova M. Hrabeta J. Histone deacetylase inhibitors as anticancer drugs Int. J. Mol. Sci 2017 18 141410.3390/ijms18071414553590628671573Search in Google Scholar

[50]Piekarzewska M., Zajenkowska-Kozłowska A.: Stan zdrowia ludności. W: Stan zdrowia ludności Polski w 2014 r., red.: M. Piekarzewska, A. Zajenkowska-Kozłowska. Główny Urząd Statystyczny, Warszawa, 2016, 76 Piekarzewska M. Zajenkowska-Kozłowska A. Stan zdrowia ludności W: Stan zdrowia ludności Polski w 2014 r., red.: M. Piekarzewska, A. Zajenkowska-Kozłowska. Główny Urząd Statystyczny, Warszawa 2016 76Search in Google Scholar

[51]Macchione I.G., Lopetuso L.R., Ianiro G., Napoli M., Gibiino G., Rizzatti G., Petito V., Gasbarrini A., Scaldaferri F.: Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders. Eur. Rev. Med. Pharmacol. Sci., 2019; 23: 8075-8083 Macchione I.G. Lopetuso L.R. Ianiro G. Napoli M. Gibiino G. Rizzatti G. Petito V. Gasbarrini A. Scaldaferri F. Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders Eur. Rev. Med. Pharmacol. Sci 2019 23 8075 8083Search in Google Scholar

[52]Jayachandran M., Chung S.S., Xu B.: A critical review of the relationship between dietary components, the gut microbe Akker-mansia muciniphila, and human health. Crit. Rev. Food Sci. Nutr., 2020; 60: 2265-2276 Jayachandran M. Chung S.S. Xu B. A critical review of the relationship between dietary components, the gut microbe Akker-mansia muciniphila, and human health Crit. Rev. Food Sci. Nutr 2020 60 2265 227610.1080/10408398.2019.163278931257904Search in Google Scholar

[53]Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I.: Microbial ecology: Human gut microbes associated with obesity. Nature, 2006; 444: 1022-1023 Ley R.E. Turnbaugh P.J. Klein S. Gordon J.I. Microbial ecology: Human gut microbes associated with obesity Nature 2006 444 1022 102310.1038/4441022a17183309Search in Google Scholar

[54]Shin J., Noh J.R., Chang D.H., Kim Y.H., Kim M.H., Lee E.S., Cho S., Ku B.J., Rhee M.S., Kim B.C. i wsp.: Elucidation of Akker-mansia muciniphila probiotic traits driven by mucin depletion. Front. Microbiol., 2019; 10: 1137 Shin J. Noh J.R. Chang D.H. Kim Y.H. Kim M.H. Lee E.S. Cho S. Ku B.J. Rhee M.S. Kim B.C. i wsp. Elucidation of Akker-mansia muciniphila probiotic traits driven by mucin depletion Front. Microbiol 2019 10 113710.3389/fmicb.2019.01137653887831178843Search in Google Scholar

[55]Pascale A., Marchesi N., Govoni S., Coppola A., Gazzaruso C.: The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: New insights into old diseases. Curr. Opin. Pharmacol., 2019; 49: 1-5 Pascale A. Marchesi N. Govoni S. Coppola A. Gazzaruso C. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: New insights into old diseases Curr. Opin. Pharmacol 2019 49 1 510.1016/j.coph.2019.03.01131015106Search in Google Scholar

[56]Kim M.H., Jee J.H., Park S., Lee M.S., Kim K.W., Lee M.K.: Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. J. Endocrinol., 2014; 220: 117-128 Kim M.H. Jee J.H. Park S. Lee M.S. Kim K.W. Lee M.K. Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling J. Endocrinol 2014 220 117 12810.1530/JOE-13-038124233023Search in Google Scholar

[57]Wu H., Esteve E., Tremaroli V., Khan M.T., Caesar R., Mannerås-Holm L., Ståhlman M., Olsson L.M., Serino M., Planas-Fè-lix M. i wsp.: Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med., 2017; 23: 850-858 Wu H. Esteve E. Tremaroli V. Khan M.T. Caesar R. Mannerås-Holm L. Ståhlman M. Olsson L.M. Serino M. Planas-Fè-lix M. i wsp. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug Nat. Med 2017 23 850 85810.1038/nm.434528530702Search in Google Scholar

[58]Ramos G.P., Papadakis K.A.: Mechanisms of disease: Inflammatory bowel diseases. Mayo Clin. Proc., 2019; 94: 155-165 Ramos G.P. Papadakis K.A. Mechanisms of disease: Inflammatory bowel diseases Mayo Clin. Proc 2019 94 155 16510.1016/j.mayocp.2018.09.013638615830611442Search in Google Scholar

[59]Hall A.B., Yassour M., Sauk J., Garner A., Jiang X., Arthur T., Lagoudas G.K., Vatanen T., Fornelos N., Wilson R. i wsp.: A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med., 2017; 9: 103 Hall A.B. Yassour M. Sauk J. Garner A. Jiang X. Arthur T. Lagoudas G.K. Vatanen T. Fornelos N. Wilson R. i wsp. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients Genome Med 2017 9 10310.1186/s13073-017-0490-5570445929183332Search in Google Scholar

[60]Kump P., Wurm P., Gröchenig H.P., Wenzl H., Petritsch W., Halwachs B., Wagner M., Stadlbauer V., Eherer A., Hoffmann K.M. i wsp.: The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment. Pharmacol. Ther., 2018; 47: 67-77 Kump P. Wurm P. Gröchenig H.P. Wenzl H. Petritsch W. Halwachs B. Wagner M. Stadlbauer V. Eherer A. Hoffmann K.M. i wsp. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis Aliment. Pharmacol. Ther 2018 47 67 7710.1111/apt.14387576550129052237Search in Google Scholar

[61]Xu Y., Wang N., Tan H.Y., Li S., Zhang C., Feng Y.: Function of Akkermansia muciniphila in obesity: Interactions with lipid metabolism, immune response and gut systems. Front. Microbiol., 2020; 11: 219 Xu Y. Wang N. Tan H.Y. Li S. Zhang C. Feng Y. Function of Akkermansia muciniphila in obesity: Interactions with lipid metabolism, immune response and gut systems Front. Microbiol 2020 11 21910.3389/fmicb.2020.00219704654632153527Search in Google Scholar

[62]Aron-Wisnewsky J., Gaborit B., Dutour A., Clement K.: Gut microbiota and non-alcoholic fatty liver disease: New insights. Clin. Microbiol. Infect., 2013; 19: 338-348 Aron-Wisnewsky J. Gaborit B. Dutour A. Clement K. Gut microbiota and non-alcoholic fatty liver disease: New insights Clin. Microbiol. Infect 2013 19 338 34810.1111/1469-0691.1214023452163Search in Google Scholar

[63]Fukui H.: Gut microbiota and host reaction in liver diseases. Microorganisms, 2015; 3: 759-791 Fukui H. Gut microbiota and host reaction in liver diseases Microorganisms 2015 3 759 79110.3390/microorganisms3040759502326127682116Search in Google Scholar

[64]Van Best N., Jansen P.L., Rensen S.S.: The gut microbiota of nonalcoholic fatty liver disease: Current methods and their interpretation. Hepatol. Int., 2015; 9: 406-415 Van Best N. Jansen P.L. Rensen S.S. The gut microbiota of nonalcoholic fatty liver disease: Current methods and their interpretation Hepatol. Int 2015 9 406 41510.1007/s12072-015-9640-2447301926067771Search in Google Scholar

[65]Szewczyk A., Witecka A., Kiersztan A.: The role of gut microbiota in the pathogenesis of neuropsychiatric and neurodegenerative diseases. Postępy Hig. Med. Dośw., 2019; 73: 865-886 Szewczyk A. Witecka A. Kiersztan A. The role of gut microbiota in the pathogenesis of neuropsychiatric and neurodegenerative diseases Postępy Hig. Med. Dośw 2019 73 865 88610.5604/01.3001.0013.7326Search in Google Scholar

[66]Jones L.A., Sun E.W., Martin A.M., Keating D.J.: The everchanging roles of serotonin. Int. J. Biochem. Cell Biol., 2020; 125: 105776 Jones L.A. Sun E.W. Martin A.M. Keating D.J. The everchanging roles of serotonin Int. J. Biochem. Cell Biol 2020 125 10577610.1016/j.biocel.2020.10577632479926Search in Google Scholar

[67]Yaghoubfar R., Behrouzi A., Ashrafian F., Shahryari A., Moradi H.R., Choopani S., Hadifar S., Vaziri F., Nojoumi S.A., Fateh A. i wsp.: Modulation of serotonin signaling/metabolism by Akker-mansia muciniphila and its extracellular vesicles through the gutbrain axis in mice. Sci. Rep., 2020; 10: 22119 Yaghoubfar R. Behrouzi A. Ashrafian F. Shahryari A. Moradi H.R. Choopani S. Hadifar S. Vaziri F. Nojoumi S.A. Fateh A. i wsp. Modulation of serotonin signaling/metabolism by Akker-mansia muciniphila and its extracellular vesicles through the gutbrain axis in mice Sci. Rep 2020 10 2211910.1038/s41598-020-79171-8774764233335202Search in Google Scholar

[68]Macia L., Nanan R., Hosseini-Beheshti E., Grau G.E.: Host- and microbiota-derived extracellular vesicles, immune function, and disease development. Int. J. Mol. Sci. 2019; 21: 107 Macia L. Nanan R. Hosseini-Beheshti E. Grau G.E. Host- and microbiota-derived extracellular vesicles, immune function, and disease development Int. J. Mol. Sci 2019 21 10710.3390/ijms21010107698200931877909Search in Google Scholar

[69]Han E.C, Choi S.Y., Lee Y., Park J.W., Hong S.H., Lee H.J.: Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice. FASEB J., 2019; 33: 13412-13422 Han E.C Choi S.Y. Lee Y. Park J.W. Hong S.H. Lee H.J. Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice FASEB J 2019 33 13412 1342210.1096/fj.201901575R689404631545910Search in Google Scholar

[70]Olson C.A., Vuong H.E., Yano J.M., Liang Q.Y., Nusbaum D.J., Hsiao E.Y.: The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell, 2018; 173: 1728-1741.e13 Olson C.A. Vuong H.E. Yano J.M. Liang Q.Y. Nusbaum D.J. Hsiao E.Y. The gut microbiota mediates the anti-seizure effects of the ketogenic diet Cell 2018 173 1728 1741 e1310.1016/j.cell.2018.04.027600387029804833Search in Google Scholar

[71]Kang D.W., Adams J.B., Gregory A.C., Borody T., Chittick L., Fasano A., Khoruts A., Geis E., Maldonado J., McDonough-Means S. i wsp.: Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome, 2017; 5: 10 Kang D.W. Adams J.B. Gregory A.C. Borody T. Chittick L. Fasano A. Khoruts A. Geis E. Maldonado J. McDonough-Means S. i wsp. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study Microbiome 2017 5 1010.1186/s40168-016-0225-7526428528122648Search in Google Scholar

[72]Kraeuter A.K., Guest P.C., Sarnyai Z.: The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol. Biol., 2019; 1916: 105-111 Kraeuter A.K. Guest P.C. Sarnyai Z. The Y-maze for assessment of spatial working and reference memory in mice Methods Mol. Biol 2019 1916 105 11110.1007/978-1-4939-8994-2_1030535688Search in Google Scholar

[73]Ou Z., Deng L., Lu Z., Wu F., Liu W., Huang D., Peng Y.: Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer’s disease. Nutr. Diabetes, 2020; 10: 12 Ou Z. Deng L. Lu Z. Wu F. Liu W. Huang D. Peng Y. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer’s disease Nutr. Diabetes 2020 10 1210.1038/s41387-020-0115-8717664832321934Search in Google Scholar

[74]Michalovich D., Rodriguez-Perez N., Smolinska S., Pirozynski M., Mayhew D., Uddin S., Van Horn S., Sokolowska M., Altunbulakli C., Eljaszewicz A. i wsp.: Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients. Nat. Commun., 2019; 10: 5711 Michalovich D. Rodriguez-Perez N. Smolinska S. Pirozynski M. Mayhew D. Uddin S. Van Horn S. Sokolowska M. Altunbulakli C. Eljaszewicz A. i wsp. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients Nat. Commun 2019 10 571110.1038/s41467-019-13751-9691109231836714Search in Google Scholar

[75]Farrokhi A.S., Darabi N., Yousefi B., Askandar R.H., Shariati M., Eslami M.: Is it true that gut microbiota is considered as panacea in cancer therapy? J. Cell. Physiol., 2019; 234: 14941-14950 Farrokhi A.S. Darabi N. Yousefi B. Askandar R.H. Shariati M. Eslami M. Is it true that gut microbiota is considered as panacea in cancer therapy? J Cell. Physiol 2019 234 14941 1495010.1002/jcp.2833330786013Search in Google Scholar

[76]Routy B., Le Chatelier E., Derosa L., Duong, C.P., Alou, M.T., Daillère R., Fluckiger A., Messaoudene M., Rauber C., Roberti M.P. i wsp.: Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 2018; 359: 91-97 Routy B. Le Chatelier E. Derosa L. Duong C.P. Alou M.T. Daillère R. Fluckiger A. Messaoudene M. Rauber C. Roberti M.P. i wsp. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors Science 2018 359 91 9710.1126/science.aan370629097494Search in Google Scholar